TP53 and glioma: GSEA revealed that the high NSUN6 expression was associated with enrichment of tumor‐suppressive pathways, including p53 signaling, E2F target inhibition, mTORC1 regulation, glycolysis and xenobiotic metabolism – all of which are central to glioma cell cycle control, DNA damage response and metabolic adaptation.